A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis
- PMID: 1953532
- DOI: 10.1111/j.1445-5994.1991.tb01346.x
A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis
Abstract
Sixty-four patients with chronic bronchitis with a history of recurrent respiratory tract infections were admitted to a double-blind randomised controlled study in which the efficacy of an oral vaccine containing killed Haemophilus influenzae in preventing acute exacerbations of chronic bronchitis was compared with placebo. Patients given vaccine developed fewer acute infective episodes. Although the numbers of patients who required antibiotic therapy in the two groups were not significantly different, the number of antibiotic prescriptions given to the vaccinated group of patients was significantly less than that required by the control group. A reduction in colonisation with Haemophilus influenzae occurred in the active group, which was maximal 14 weeks after the onset of the study.
Similar articles
-
Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2017 Jun 19;6(6):CD010010. doi: 10.1002/14651858.CD010010.pub3. Cochrane Database Syst Rev. 2017. PMID: 28626902 Free PMC article. Review.
-
Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2014 Sep 9;(9):CD010010. doi: 10.1002/14651858.CD010010.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2017 Jun 19;6:CD010010. doi: 10.1002/14651858.CD010010.pub3. PMID: 25201571 Updated. Review.
-
Protection against recurrent acute bronchitis after oral immunization with killed Haemophilus influenzae.Med J Aust. 1990 Apr 16;152(8):413-6. doi: 10.5694/j.1326-5377.1990.tb125268.x. Med J Aust. 1990. PMID: 2184330 Clinical Trial.
-
Reduction in the incidence of acute bronchitis by an oral Haemophilus influenzae vaccine in patients with chronic bronchitis in the highlands of Papua New Guinea.Am Rev Respir Dis. 1991 Aug;144(2):324-30. doi: 10.1164/ajrccm/144.2.324. Am Rev Respir Dis. 1991. PMID: 1859055 Clinical Trial.
-
Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease.Lancet. 1985 Dec 21-28;2(8469-70):1395-7. doi: 10.1016/s0140-6736(85)92559-0. Lancet. 1985. PMID: 2867396 Clinical Trial.
Cited by
-
Nontypeable Haemophilus influenzae: pathogenesis and prevention.Microbiol Mol Biol Rev. 1998 Jun;62(2):294-308. doi: 10.1128/MMBR.62.2.294-308.1998. Microbiol Mol Biol Rev. 1998. PMID: 9618443 Free PMC article.
-
Oral non-typable Haemophilus influenzae enhances physiological mechanism of airways protection.Clin Exp Immunol. 2010 Jul 1;161(1):127-33. doi: 10.1111/j.1365-2249.2010.04142.x. Epub 2010 Apr 9. Clin Exp Immunol. 2010. PMID: 20408861 Free PMC article. Clinical Trial.
-
Optimizing economic outcomes in acute exacerbations of chronic bronchitis.Pharmacotherapy. 2002 Jan;22(1 Pt 2):12S-17S; discussion 30S-32S. doi: 10.1592/phco.22.2.12s.33134. Pharmacotherapy. 2002. PMID: 11791624 Free PMC article.
-
Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2017 Jun 19;6(6):CD010010. doi: 10.1002/14651858.CD010010.pub3. Cochrane Database Syst Rev. 2017. PMID: 28626902 Free PMC article. Review.
-
Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.Clin Microbiol Rev. 2001 Apr;14(2):336-63. doi: 10.1128/CMR.14.2.336-363.2001. Clin Microbiol Rev. 2001. PMID: 11292642 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical